All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
The U.S. FDA has posted notice of an advisory issued by Dublin-based Medtronic plc, regarding the Heartware ventricular assist device due to a pump weld defect, which the agency has identified as a class I recall. The recall affects devices that have been in use since 2006 and is associated with the entry of moisture into the pump center post, which can de-magnetize the magnets and thus trigger malrotation and consequently damage to the welds.